<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell Death Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell Death Dis</journal-id>
      <journal-title-group>
        <journal-title>Cell Death &amp; Disease</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2041-4889</issn>
      <publisher>
        <publisher-name>Nature Publishing Group</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24176846</article-id>
      <article-id pub-id-type="pmc">3920964</article-id>
      <article-id pub-id-type="pii">cddis2013410</article-id>
      <article-id pub-id-type="doi">10.1038/cddis.2013.410</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cyclophilin A: a key player for human disease</article-title>
        <alt-title alt-title-type="running">CyPA and human disease</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nigro</surname>
            <given-names>P</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="caf1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pompilio</surname>
            <given-names>G</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Capogrossi</surname>
            <given-names>M C</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <aff id="aff1"><label>1</label><institution>Centro Cardiologico Monzino-IRCCS, Laboratorio di Biologia Vascolare e Medicina Rigenerativa</institution>, Milan, <country>Italy</country></aff>
        <aff id="aff2"><label>2</label><institution>Laboratorio di Patologia Vascolare, Istituto Dermopatico dell'Immacolata-IRCCS</institution>, Rome, <country>Italy</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="caf1"><label>*</label><institution>Laboratory of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino-IRCCS</institution>, Via Parea 4, 20138, Milan, <country>Italy</country>. Tel: +39 02 58002028; Fax: +39 02 58002342; E-mail: <email>patrizia.nigro@cardiologicomonzino.it</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>10</month>
        <year>2013</year>
      </pub-date>
      <volume>4</volume>
      <issue>10</issue>
      <fpage>e888</fpage>
      <lpage/>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>07</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>10</day>
          <month>09</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>09</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Macmillan Publishers Limited</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Macmillan Publishers Limited</copyright-holder>
        <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <!--author-paid-->
          <license-p>This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Cyclophilin A (CyPA) is a ubiquitously distributed protein belonging to the immunophilin family. CyPA has peptidyl prolyl <italic>cis</italic>-<italic>trans</italic> isomerase (PPIase) activity, which regulates protein folding and trafficking. Although CyPA was initially believed to function primarily as an intracellular protein, recent studies have revealed that it can be secreted by cells in response to inflammatory stimuli. Current research in animal models and humans has provided compelling evidences supporting the critical function of CyPA in several human diseases. This review discusses recently available data about CyPA in cardiovascular diseases, viral infections, neurodegeneration, cancer, rheumatoid arthritis, sepsis, asthma, periodontitis and aging. It is believed that further elucidations of the role of CyPA will provide a better understanding of the molecular mechanisms underlying these diseases and will help develop novel pharmacological therapies.</p>
      </abstract>
      <kwd-group>
        <kwd>CyPA</kwd>
        <kwd>cardiovascular diseases</kwd>
        <kwd>viral infections</kwd>
        <kwd>neurodegeneration</kwd>
        <kwd>cancer</kwd>
        <kwd>rheumatoid arthritis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Facts</title>
      <p>
        <list list-type="bullet">
          <list-item>
            <p>CyPA is a critical mediator for cardiovascular diseases.</p>
          </list-item>
          <list-item>
            <p>High CyPA expression correlates with poor outcome of patients with inflammatory diseases.</p>
          </list-item>
          <list-item>
            <p>CyPA regulates the infection and replication of several viruses affecting humans.</p>
          </list-item>
          <list-item>
            <p>CyPA is generally overexpressed in cancer and regulates malignant transformation and metastasis.</p>
          </list-item>
          <list-item>
            <p>CyPA is a crucial mediator in Alzheimer disease and amyotrophic lateral sclerosis.</p>
          </list-item>
          <list-item>
            <p>CyPA secretion increases during pro-inflammatory diseases, such as rheumatoid arthritis, sepsis and asthma.</p>
          </list-item>
          <list-item>
            <p>CyPA expression increases with aging.</p>
          </list-item>
        </list>
      </p>
    </sec>
    <sec>
      <title>Open Questions</title>
      <p>
        <list list-type="bullet">
          <list-item>
            <p>Deepen the mechanisms by which CyPA contributes to the development of human diseases.</p>
          </list-item>
          <list-item>
            <p>Identify novel CyPA receptors able to explain all of the cellular events associated with CyPA.</p>
          </list-item>
          <list-item>
            <p>Design therapeutic agents with the capacity to block specific functions of CyPA while leaving other functions unaffected and without any effect on other CyP isoforms.</p>
          </list-item>
        </list>
      </p>
      <p>Cyclophilins (CyPs) are a family of ubiquitous proteins evolutionarily well conserved and present in all prokaryotes and eukaryotes.<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> They have peptidyl prolyl isomerase activity, which catalyzes the isomerization of peptide bonds from <italic>trans</italic> form to <italic>cis</italic> form at proline residues and facilitates protein folding.<sup><xref ref-type="bibr" rid="bib2">2</xref></sup> Human CyPs consist of 16 family members that are structurally distinct. Among them, the most abundant member is CyPA, which makes up &#x223C;0.1&#x2013;0.6% of the total cytosolic proteins.<sup><xref ref-type="bibr" rid="bib1">1</xref>, <xref ref-type="bibr" rid="bib3">3</xref></sup> CyPA was initially purified from bovine thymocytes and identified as the primary cytosolic binding protein of the immunosuppressive drug cyclosporin A (CsA).<sup><xref ref-type="bibr" rid="bib4">4</xref></sup></p>
      <p>CyPA is believed to have important roles in many biological conditions including protein folding, trafficking, and T-cell activation (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p>
      <p>Although CyPA is present intracellularly, it can be secreted from cells in response to inflammatory stimuli such as hypoxia, infection, and oxidative stress.<sup><xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref>, <xref ref-type="bibr" rid="bib26">26</xref></sup></p>
      <p>The secreted form of CyPA may mediate intercellular communication acting as an autocrine/paracrine factor. In fact, it was shown that extracellular CyPA stimulates pro-inflammatory signals in endothelial cells (EC) and vascular smooth muscle cells (VSMC),<sup><xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib26">26</xref></sup> and it is a nonmitogenic survival-enhancing autocrine factor that contributes to mouse embryonic stem cell growth.<sup><xref ref-type="bibr" rid="bib27">27</xref></sup> Further, extracellular CyPA has a potent chemotactic effect on leukocytes, monocytes, and lymphocytes.<sup><xref ref-type="bibr" rid="bib25">25</xref>, <xref ref-type="bibr" rid="bib28">28</xref></sup> The chemotactic activity of CyPA is mediated, in part, through the activation of the ubiquitous Ig like CD147 cell receptor.<sup><xref ref-type="bibr" rid="bib29">29</xref></sup></p>
      <p>A growing body of evidence suggested its involvement in key processes underling human pathologies. The objective of this article is to review the current knowledge of CyPA regarding its potential role in several human diseases in order to offer novel therapeutic strategies.</p>
    </sec>
    <sec>
      <title>CyPA and Cardiovascular Disease</title>
      <sec>
        <title>Vascular remodeling</title>
        <p>It has become clear that increases in reactive oxygen species (ROS) and inflammation represent key pathogenic mechanisms for vascular disease. For example, ROS have been implicated in the pathogenesis of neointima formation in part by promoting VSMC growth as well as stimulating pro-inflammatory events.<sup><xref ref-type="bibr" rid="bib30">30</xref></sup> In light of the major importance of CyPA in those aspect closely related to vascular remodeling, we analyzed the response to complete carotid ligation in wild-type (WT) mice, CyPA knockout (CyPA<sup>&#x2212;/&#x2212;</sup>) mice, and mice overexpressing CyPA specifically in VSMC (termed VSMC-Tg).<sup><xref ref-type="bibr" rid="bib22">22</xref></sup> Analysis of ligated arteries revealed that the intimal area as well as medial and adventitial thickening were significantly lower in CyPA<sup>&#x2212;/&#x2212;</sup> mice and significantly enhanced in VSMC-Tg mice <italic>versus</italic> WT mice. Interestingly, there was a significant decrease in the recruitment of inflammatory cells in ligated arteries of CyPA<sup>&#x2212;/&#x2212;</sup> mice and a significant increase in VSMC-Tg mice (approximately twofold) compared with WT mice. In addition, extracellular signal-regulated kinase 1/2 (ERK1/2) activation and Ki67<sup>+</sup> cells were consistently decreased in CyPA<sup>&#x2212;/&#x2212;</sup> mice after carotid ligation. These data strengthen the link between CyPA expression and VSMC proliferation and suggest that VSMC-derived CyPA is important for the recruitment of inflammatory cells.</p>
      </sec>
      <sec>
        <title>Abdominal aortic aneurysm (AAA)</title>
        <p>Inflammation has long been known to contribute to the pathogenesis of AAA. More than a decade ago, it was shown that treatment with CsA attenuated the formation of AAA in the rat model of elastase infusion.<sup><xref ref-type="bibr" rid="bib31">31</xref></sup> The authors of that study pointed out that the immunosuppressive effects of CsA would probably preclude its use in patients with aneurysms. We have recently demonstrated that deletion of CyPA in mice prevents the formation of AAA in response to infusion of angiotensin II (Ang II).<sup><xref ref-type="bibr" rid="bib32">32</xref></sup> Importantly, mice lacking CyPA were completely protected against aortic rupture leading to sudden death. Mechanistic studies revealed that deletion of CyPA reduces aortic inflammation, oxidative stress, and matrix degradation (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In a series of experiments involving bone marrow (BM) transplantation, as well as experiments in which CyPA was selectively overexpressed in VSMC, we showed that expression of CyPA in VSMC, rather than BM&#x2013;derived cells, is crucial to the development of AAA. Finally, to demonstrate its relevance to human aneurysmal disease, we showed that Ang II caused the release of CyPA and the activation of metalloproteinase 2 (MMP-2) in VSMC derived from human AAA.</p>
        <p>Recently, Prins <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib33">33</xref></sup> found that benzo[a]pyrene potentiates the pathogenesis of AAA by increasing CyPA expression. Furthermore, simvastatin-treated patients with AAA exhibited lower CyPA mRNA, as well as CyPA intracellular protein levels.<sup><xref ref-type="bibr" rid="bib34">34</xref></sup> Thus, the interference with signaling pathways leading to CyPA may reveal a new strategy in the treatment of AAA.</p>
      </sec>
      <sec>
        <title>Atherosclerosis</title>
        <p>One of the major causes of AAA is atherosclerosis, a disease characterized by chronic inflammation of the arterial wall.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup> Based on the premise that atherosclerosis stimulates AAA, we hypothesized that CyPA would necessarily have a significant impact on atherosclerosis development. We have characterized five important pathological mechanisms by which CyPA promotes atherosclerosis (<xref ref-type="fig" rid="fig2">Figure 2</xref>).<sup><xref ref-type="bibr" rid="bib36">36</xref></sup> First, CyPA stimulates low-density lipoprotein (LDL) uptake in the vessel wall by regulating the expression of scavenger receptors. Second, CyPA increases EC activation and inflammation by increasing vascular cell adhesion molecule 1 (VCAM-1) expression. Third, CyPA decreases endothelial nitric oxide synthase (eNOS) expression through kruppel-like factor 2 (KLF2) transcriptional repression in EC. Fourth, CyPA is a key determinant for tumor necrosis factor alpha (TNF-<italic>&#x3B1;</italic>)-induced EC apoptosis. Finally, CyPA stimulates recruitment of inflammatory cells derived from the BM to the aortic wall.</p>
        <p>Thus, CyPA may have an important role in several stages of atherosclerosis. This observation is also supported by recent papers suggesting that CyPA is involved in the early phase of atherosclerosis by regulating fatty streak formation,<sup><xref ref-type="bibr" rid="bib37">37</xref></sup> and later phases by affecting plaque rupture<sup><xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib38">38</xref></sup> and thrombosis that complicate the disease.<sup><xref ref-type="bibr" rid="bib39">39</xref>, <xref ref-type="bibr" rid="bib40">40</xref></sup></p>
        <p>Based on the literature reported above, it is now clear that CyPA is a crucial mediator of vascular remodeling, AAA, and atherosclerosis, three diseases that share common pathways (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
      </sec>
      <sec>
        <title>Cardiac diseases</title>
        <p>Inflammation triggered by oxidative stress is the cause of many human cardiac diseases including hypertrophy, myocardial ischemia, and coronary artery disease.<sup><xref ref-type="bibr" rid="bib41">41</xref></sup> Considering the role of CyPA in inflammation and ROS generation, we studied CyPA functions in heart disease. In particular, we evaluated the role of CyPA in Ang II&#x2013;induced cardiac hypertrophy.<sup><xref ref-type="bibr" rid="bib42">42</xref></sup> Interestingly, mice lacking CyPA exhibited significantly less Ang II&#x2013;induced cardiac hypertrophy. Most importantly, we proved that CyPA is required for Ang II&#x2013;mediated cardiac hypertrophy by directly potentiating ROS production, stimulating the proliferation and migration of cardiac fibroblasts, and promoting cardiac myocyte hypertrophy.</p>
        <p>In addition, May and coworkers<sup><xref ref-type="bibr" rid="bib43">43</xref></sup> demonstrated that CyPA is involved in myocardial ischemia and reperfusion injury.</p>
        <p>Emerging data suggested that CyPA might be a valuable marker for predicting the severity of acute coronary syndromes. Yan <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib44">44</xref></sup> reported that serum CyPA concentration in unstable angina and acute myocardial infarction subjects are significantly higher than those in patients with stable angina and controls.</p>
        <p>This study was confirmed by Satoh <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib45">45</xref></sup> that found that plasma levels of CyPA correlated with the anatomical severity of stable coronary artery disease.</p>
        <p>In summary, CyPA is a critical determinant of cardiac hypertrophy, myocardial ischemia, and reperfusion injury and may be a helpful biomarker of coronary artery disease.</p>
      </sec>
    </sec>
    <sec>
      <title>CyPA and Diabetes</title>
      <p>Recently, Ramachandran <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib46">46</xref></sup> presented evidence for a significant role of CyPA in the pathogenesis of diabetes. They performed a proteomic analysis of high glucose-primed monocytes, and identified CyPA as a potential secretory marker of inflammation in type 2 diabetes. Specifically, they reported that CyPA expression is reduced in circulating monocytes from patients with type 2 diabetes. In addition, they found that the levels of CyPA in plasma samples of patients with diabetes and coronary artery disease are higher in comparison with plasma obtained from healthy volunteers. These data suggested that CyPA secreted from monocytes could be an important pro-inflammatory stimulus for vascular inflammation in patients with diabetes.</p>
    </sec>
    <sec>
      <title>CyPA and Viral Infection</title>
      <sec>
        <title>CyPA and human immunodeficiency virus (HIV-1)</title>
        <p>CyPA has been extensively studied from the gene to protein level during HIV-1 infection. CyPA is encoded by the peptidyl prolyl isomerase A (<italic>PPIA</italic>) gene, and regulatory <italic>PPIA</italic> polymorphisms were found to be a component of genetic susceptibility to HIV-1 infection or disease progression.<sup><xref ref-type="bibr" rid="bib47">47</xref></sup> In addition, analysis of sera from HIV-1-infected individuals has revealed higher protein concentrations of CyPA (about fourfold) compared with sera of healthy controls.<sup><xref ref-type="bibr" rid="bib48">48</xref></sup> Interestingly, HIV-1 replication was decreased in human CD4<sup>+</sup> T cells when CyPA was knocked out.<sup><xref ref-type="bibr" rid="bib49">49</xref></sup> Molecular insights have revealed that CyPA can interact with HIV capsid proteins (CA domain).<sup><xref ref-type="bibr" rid="bib5">5</xref></sup> Furthermore, CyPA interacts with HIV accessory proteins, such as the viral protein R (Vpr) and Nef to facilitate a step in the viral life cycle between penetration and reverse transcription.<sup><xref ref-type="bibr" rid="bib50">50</xref>, <xref ref-type="bibr" rid="bib51">51</xref></sup> Recently, it has been reported that CyPA in dendritic cells could recognize the newly synthesized HIV-1 CA domain and subsequently prompt an interferon type I (IFN-I) response through activation of IRF3.<sup><xref ref-type="bibr" rid="bib52">52</xref></sup> Therefore, packaging of host CyPA into HIV particles is an important step in HIV morphogenesis and essential for HIV replication.</p>
      </sec>
      <sec>
        <title>CyPA and hepatitis virus</title>
        <p>Similar to HIV-1, several lines of evidence indicate that CyPA positively regulates the replication of hepatitis C virus (HCV).<sup><xref ref-type="bibr" rid="bib53">53</xref></sup> Knockdown of endogenous CyPA significantly hampered HCV RNA replication and viral protein expression.<sup><xref ref-type="bibr" rid="bib54">54</xref></sup> Molecular studies provided evidence that CyPA enhances the replication of HCV by binding to the non-structural 5A (NS5A) and NS5B protein of HCV.<sup><xref ref-type="bibr" rid="bib55">55</xref></sup></p>
        <p>CyPA is also important for hepatitis B virus (HBV) infection. Higher serum CyPA levels were detected in chronic hepatitis B patients than in healthy individuals.<sup><xref ref-type="bibr" rid="bib56">56</xref></sup></p>
        <p>Studies on molecular mechanisms regulating HBV replication showed that CyPA interacts with the small surface proteins (SHBs) of the HBV surface antigen (HBsAg).<sup><xref ref-type="bibr" rid="bib56">56</xref></sup> It was hypothesized that CyPA binds to SHBs and is secreted along with HBsAg particles.<sup><xref ref-type="bibr" rid="bib53">53</xref></sup> Thus, CyPA may function as a cell-intrinsic sensor able to recognize HCV and HBV proteins in order to promote viral infection and replication.</p>
      </sec>
      <sec>
        <title>CyPA and influenza A virus</title>
        <p>CyPA was found in the core of the influenza virion<sup><xref ref-type="bibr" rid="bib57">57</xref></sup> and was upregulated upon infection by avian H9N2 influenza virus in AGS cells (a human gastric carcinoma cell line).<sup><xref ref-type="bibr" rid="bib58">58</xref></sup> Liu <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib59">59</xref></sup> revealed that overexpression of CyPA blocked influenza A virus replication, whereas the depletion of endogenous CyPA resulted in enhanced production of influenza A virus. Furthermore, CyPA was found to interact with the matrix protein 1 (M1) affecting the early stage of viral replication. Finally, CyPA was able to restrict influenza virus replication through accelerating degradation of the M1 protein.</p>
      </sec>
      <sec>
        <title>CyPA and other viruses</title>
        <p>It was reported that vaccinia virus (VV) infection led to an impressive increase in CyPA stability and CyPA is incorporated into the virus particle during morphogenesis.<sup><xref ref-type="bibr" rid="bib60">60</xref></sup> In addition, CyPA was found to act as a chaperone for the nucleocapsid protein of the vesicular stomatitis virus (VSV).<sup><xref ref-type="bibr" rid="bib61">61</xref></sup></p>
        <p>CyPA was also reported to regulate severe acute respiratory syndrome coronavirus (SARS-CoV) replication through binding to the nucleocapsid protein and incorporation into particles.<sup><xref ref-type="bibr" rid="bib62">62</xref></sup></p>
        <p>Then, it was shown that CyPA is required for the host IFN-I response in rotavirus (RV) infection of MA104 cells.<sup><xref ref-type="bibr" rid="bib63">63</xref></sup> Finally, Keyes <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib64">64</xref></sup> demonstrated that CyPA expression is an important factor in human cytomegalovirus (HCMV) infection and reactivation.</p>
        <p>In light of the major importance of CyPA in the regulation of infectivity and replication of several viruses, it is worth proposing CyPA as target for anti-viral therapy.</p>
      </sec>
    </sec>
    <sec>
      <title>Protozoan Parasites</title>
      <p>An emerging body of literature is reporting CyPA importance in the growth of protozoan parasites affecting humans. It has been suggested that the mammalian host cell CyPA seems to be involved in the intracellular replication cycle of <italic>Leishmania major</italic> parasites, as CyPA siRNA interference or CsA reduced the parasite burden.<sup><xref ref-type="bibr" rid="bib65">65</xref></sup> Some of the small CyPs from <italic>Plasmodium falciparum</italic> and <italic>Toxoplasma gondii</italic> (i.e. TgCyP18) have shown similar inhibitory profiles as those established for the human CyPA.<sup><xref ref-type="bibr" rid="bib66">66</xref>, <xref ref-type="bibr" rid="bib67">67</xref></sup></p>
      <p>The involvement of CyPA in protozoan parasite growth was also supported by the fact that CsA has anti-parasitic activity against a wide variety of parasites<sup><xref ref-type="bibr" rid="bib68">68</xref></sup> with the exception of <italic>Leishmania</italic>.<sup><xref ref-type="bibr" rid="bib69">69</xref></sup></p>
    </sec>
    <sec>
      <title>CyPA and Cancer</title>
      <sec>
        <title>Upregulation of CyPA</title>
        <p>There is now an established body of knowledge about the role of CyPA in cancer. Indeed, various reports have shown that CyPA is upregulated in cancer and is a key determinant for malignant transformation and metastasis.<sup><xref ref-type="bibr" rid="bib70">70</xref>, <xref ref-type="bibr" rid="bib71">71</xref></sup></p>
        <p>In small cell lung cancer, overexpressed CyPA stimulates cancer cell growth, whereas CyPA knockdown slows down cancer cell growth.<sup><xref ref-type="bibr" rid="bib70">70</xref>, <xref ref-type="bibr" rid="bib72">72</xref></sup></p>
        <p>CyPA is involved in diverse pathological processes of cancer development. Specifically, it has been reported that overexpressed CyPA in many cancers: (1) helps cancer proliferation,<sup><xref ref-type="bibr" rid="bib73">73</xref></sup> (2) regulates cell cycle progression,<sup><xref ref-type="bibr" rid="bib74">74</xref></sup> (3) blocks apoptosis,<sup><xref ref-type="bibr" rid="bib75">75</xref></sup> and (4) promotes cell migration/invasion.<sup><xref ref-type="bibr" rid="bib76">76</xref></sup></p>
        <p>Interestingly, CyPA expression is influenced by chemotherapeutic agents. For example, treatment with anti-cancer drugs such as 5-aza-2-deoxycytidine, celecoxib, and 5-fluorouracil, decreases CyPA expression in cancer cells.<sup><xref ref-type="bibr" rid="bib77">77</xref>, <xref ref-type="bibr" rid="bib78">78</xref>, <xref ref-type="bibr" rid="bib79">79</xref></sup> Moreover, CsA and sanglifehrin A (SfA), the two immunosuppressive drugs that bind CyPA, increase the chemotherapeutic effect of cisplatin in glioblastoma multiforme.<sup><xref ref-type="bibr" rid="bib80">80</xref></sup></p>
      </sec>
      <sec>
        <title>Transcriptional regulation of CyPA</title>
        <p>Recently, upregulation of CyPA in cancers was reported to be controlled by p53 and HIF1<italic>&#x3B1;</italic> (<xref ref-type="fig" rid="fig4">Figure 4</xref>), two critical transcription factors for cancer development. It was shown that CyPA protein is upregulated by p53-induced apoptotic conditions and CyPA may also confer p53 stability through its PPIase activity.<sup><xref ref-type="bibr" rid="bib81">81</xref></sup> However, overexpressed CyPA inhibits hypoxia- and cisplatin-induced cell death in a p53- independent manner. Furthermore, it was found that, under hypoxic conditions, CyPA, whose promoter contains the hypoxia response element (HRE) motif, can be induced by HIF1<italic>&#x3B1;</italic>.<sup><xref ref-type="bibr" rid="bib75">75</xref></sup> Thus, the regulatory relations of CyPA with p53 and HIF1<italic>&#x3B1;</italic> may present a new insight in understanding CyPA function during cancer development.</p>
      </sec>
      <sec>
        <title>Drug resistance</title>
        <p>Choi <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib75">75</xref></sup> also found that CyPA overexpression decreases cisplatin-induced cell death, whereas CyPA knockdown lower cell survival rates. These results suggested that CyPA overexpression may lead to drug resistance, which results in a bad outcome of chemotherapy. Subsequent oligo-microarray analysis by Yu and collaborators<sup><xref ref-type="bibr" rid="bib82">82</xref></sup> revealed that CyPA can upregulate the expression of many cytokine and drug resistance-related genes including drug metabolism and drug transport-related genes. Some of these genes, such as IL-6, multidrug resistance-associated protein 2 (MRP2), MRP3, microsomal glutathione <italic>S</italic>-transferase 1 (MGST1), and glutathione transferase zeta 1 (GSTZ1), may contribute to drug resistance.<sup><xref ref-type="bibr" rid="bib83">83</xref></sup> In addition, CyPA promoted the expression of many ATP-binding cassette (ABC) transporters,<sup><xref ref-type="bibr" rid="bib82">82</xref></sup> which are able to reduce cellular drug accumulation and consequently induce drug resistance. It was also observed that liver cells stably expressing CyPA (SK-Hep1-CyPA) show an increased resistance for the anti-cancer drugs doxorubicin and vincristine. Also, the accumulation of doxorubicin was reduced in SK-Hep1-CyPA cells. These data suggest that the elevated expression of CyPA may contribute to clinical resistance to chemotherapy.</p>
      </sec>
      <sec>
        <title><italic>In vivo</italic> studies</title>
        <p>A report on CyPA in non-small-cell lung cancer revealed that CyPA knockdown has a significant effect on tumor growth <italic>in vivo</italic>.<sup><xref ref-type="bibr" rid="bib72">72</xref></sup> Two non-small-cell lung cancer cell lines, 5M2 and LC-103H, stably transfected with pSUPER-CyPA RNAi were grown as xenografts in severe combined immunodeficient (SCID) mice, and CyPA knockdown cells yielded slower-growing tumors than the cells transfected with scrambled RNAi. This effect was confirmed by overexpressing CyPA in the small airway epithelial cell line, S1LEK3. These cells resulted in faster growing xenografts in SCID mice compared with cells transfected with the empty vector. Large tumors were observed in the CyPA-overexpressing group, whereas none was observed in the vector group.<sup><xref ref-type="bibr" rid="bib72">72</xref></sup></p>
        <p>Other interesting data by Li <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib73">73</xref></sup> revealed that intra-tumor injection of Pgenesil-2-CypA-shRNA decreases tumor development in nude mice. These data indicated that CyPA suppression by shRNA could significantly decrease tumor growth <italic>in vivo</italic>, with no apparent toxicity at the dose used.</p>
      </sec>
    </sec>
    <sec>
      <title>CyPA and Nervous System Degeneration</title>
      <sec>
        <title>Alzheimer disease</title>
        <p>A growing body of evidence suggests oxidative stress involvement in neurodegenerative diseases.<sup><xref ref-type="bibr" rid="bib84">84</xref></sup> In addition, many papers showed the contribution of CyPA in oxidative stress mediated-diseases.<sup><xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib32">32</xref></sup> Recently Bell <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib85">85</xref></sup> reported the involvement of CyPA in Alzheimer disease. In particular, they showed that astrocyte-derived human ApoE4 leads to an age-dependent progressive blood&#x2013;brain barrier (BBB) breakdown (<xref ref-type="fig" rid="fig5">Figure 5</xref>). This event is driven by CyPA that initiates a pro-inflammatory pathway activating nuclear factor kappa B (NF-<italic>&#x3BA;</italic>B) and MMP-9. The activation of this pro-inflammatory pathway in brain capillary pericytes determines the release of neurotoxic molecules from the vessels, damaging neurons and affecting their synaptic connections.</p>
        <p>Another recent paper by Kayenda <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib86">86</xref></sup> illustrated that the CD147 receptor, by interacting with CyPA, can influence amyloid-<italic>&#x3B2;</italic> peptide levels, a protein that is central to Alzheimer's disease pathogenesis. Furthermore, it has been shown that copper affects the secretion of CyPA.<sup><xref ref-type="bibr" rid="bib87">87</xref></sup> This mechanism is of particular relevance in the nervous system regulation as copper dyshomeostasis is responsible for the neurological symptoms observed in genetically inherited copper-dependent disorders (i.e., Menkes' and Wilson's diseases), as well as Alzheimer disease.</p>
      </sec>
      <sec>
        <title>Amyotrophic lateral sclerosis (ALS)</title>
        <p>It has been reported that mutations in Cu/Zn superoxide dismutase-1 (SOD1) can cause familial ALS.<sup><xref ref-type="bibr" rid="bib88">88</xref></sup> SOD1 transgenic mice that have the mutant human SOD1 (G93A) substitution are used as a model for ALS. Proteomic analysis of spinal cord of the G93A SOD1 mouse showed a variation in the isoform pattern of CyPA.<sup><xref ref-type="bibr" rid="bib89">89</xref></sup> In addition, overexpressed WT CyPA, but not CyPA with a rotamase active site point mutation, protected cells expressing ALS-related mutant SOD from death.<sup><xref ref-type="bibr" rid="bib90">90</xref></sup> Mechanistic insights revealed that CyPA is involved in motor neuronal cell death in ALS model mice by interacting with apoptosis-inducing factor (AIF).<sup><xref ref-type="bibr" rid="bib14">14</xref></sup> In particular, in the spinal cords of G93A SOD1 mice, the expressions of CyPA and AIF were detected in the motor neurons, and AIF co-translocated to the motor neuronal nuclei with CyPA. Furthermore, Basso <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib91">91</xref></sup> found that CyPA is significantly enriched in the insoluble fraction of spinal cords of ALS patients, thus may contribute to protein aggregate formation in ALS. Finally, Nardo <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib92">92</xref></sup> identified CyPA as biomarker for ALS in peripheral blood mononuclear cells and find an association with disease progression.</p>
      </sec>
    </sec>
    <sec>
      <title>CyPA and Rheumatoid Arthritis (RA)</title>
      <p>Of interest, RA has been the first condition in which a secreted form of CyPA has been demonstrated in extracellular fluids. As shown by Billich <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib93">93</xref></sup>, CyPA was increased in the synovial fluids of RA patients compared with knee osteoarthritis patients. Won-Ha Lee and his colleagues<sup><xref ref-type="bibr" rid="bib94">94</xref></sup> extended the findings on CyPA in RA by demonstrating that macrophages of the synovial lining layer constitute the major source of CyPA. In addition, they showed that stimulation of monocytes with CyPA results in increased production of inflammatory cytokines. Yang <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib95">95</xref></sup> also suggested that in RA, the CyPA-CD147 interaction might contribute to the destruction of cartilage and bone by upregulating MMP-9 expression and adhesion of monocytes/macrophages to extracellular matrix. Similarly, Wang <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib96">96</xref></sup> suggested that CyPA significantly enhances the secretion of MMP-2 and MMP-9, cell invasion, and inflammatory cytokines production of monocytes.</p>
      <p>Recently, it has been demonstrated that the increased expression of CD147 on neutrophils in RA may be responsible for CyPA-mediated neutrophil migration into the joints, elevated MMPs secretion, and cell invasion of synoviocytes.<sup><xref ref-type="bibr" rid="bib97">97</xref></sup></p>
      <p>Further, it was reported that CyPA affects IL-8-directed chemotaxis in neutrophils of RA patients.<sup><xref ref-type="bibr" rid="bib98">98</xref></sup></p>
      <p>Altogether, these data are of interest because they tighten the links between CyPA and key pathological mechanisms of RA.</p>
    </sec>
    <sec>
      <title>CyPA and Sepsis</title>
      <p>After the discovery of CyPA as an extracellular mediator in RA, the role of CyPA in other inflammatory diseases was evaluated. In 1997, Tegeder <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib99">99</xref></sup> reported that CyPA PPIase activity is significantly higher in patients with severe sepsis than healthy subjects. In addition, elevated PPIase activity was associated with high mortality. Then, Dear <italic>et al.,</italic><sup><xref ref-type="bibr" rid="bib100">100</xref></sup> by using a mouse model of sepsis based on cecal ligation and puncture, found that CyPA increased in abundance in the liver after sepsis. Moreover, Huang and collaborators<sup><xref ref-type="bibr" rid="bib101">101</xref></sup> reported that CyPA expression is modulated in peripheral lymphocytes from <italic>Pseudomonas aeruginosa</italic>-induced sepsis<sup><xref ref-type="bibr" rid="bib101">101</xref>, <xref ref-type="bibr" rid="bib102">102</xref></sup> and scalded rabbits caused by <italic>Staphylococcus aureus</italic> invasion.<sup><xref ref-type="bibr" rid="bib103">103</xref></sup></p>
      <p>Finally, a comparative proteome analysis was performed on protein extracts from human monocyte THP-1 cells stimulated with either Lipoteichoic acid (LTA) from <italic>Staphylococcus aureus</italic> (aLTA) and from <italic>Lactobacillus plantarum</italic> LTA (pLTA). Interestingly, CyPA expression was significantly changed by aLTA- or pLTA stimulation.<sup><xref ref-type="bibr" rid="bib104">104</xref></sup></p>
      <p>It is concluded that CyPA is a mediator in the pathophysiology of sepsis and might acquire a diagnostic value.</p>
    </sec>
    <sec>
      <title>CyPA and Asthma</title>
      <p>Constant and collaborators,<sup><xref ref-type="bibr" rid="bib105">105</xref></sup> using a mouse model of asthmatic inflammation, showed a correlation between CyPA and asthma. In particular, they found that (1) extracellular CyPA is elevated in the airways of asthmatic mice; (2) CyPA induces CD147-dependent chemotaxis of activated CD4<sup>+</sup> T cells <italic>in vitro</italic>; (3) <italic>in vivo</italic> treatment with anti-CD147 mAb significantly reduces the accumulation of inflammatory cells in lung tissues; and (4) anti-CD147 treatment significantly reduces airway epithelial mucin production and bronchial hyperactivity to methacholine challenge.</p>
      <p>Recently, Stemmy <italic>et al.,</italic><sup><xref ref-type="bibr" rid="bib106">106</xref></sup> by using a new murine model of chronic allergic asthma, found elevated concentrations of extracellular CyPA, but not classic chemokines, in the chronic phase of asthma. Also, blocking the activity of CyPA reduced the recruitment and persistence of leukocytes. Interestingly, it was reported that CyPA is present in nasal wash samples of asthmatic patients during the chronic phase of the disease and its levels associate with clinical parameters of disease severity.<sup><xref ref-type="bibr" rid="bib107">107</xref></sup></p>
    </sec>
    <sec>
      <title>CyPA and Periodontitis</title>
      <p>Recently Li <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib108">108</xref></sup> addressed the possible association of CyPA with pathological inflammation and destruction of periodontal tissues. They found that CyPA expression was dramatically elevated in inflamed gingival tissues as compared with healthy gingival tissues and co-localized in infiltrating macrophages and lymphocytes, as well as osteoclasts and osteoblasts in interradicular bone. As reported for other inflammatory diseases, CyPA expression correlated with MMP-1, MMP-2, and MMP-9 expression in inflamed gingiva. The same authors also collected gingival tissues and peripheral blood from patients with moderate to severe periodontitis or from healthy donors.<sup><xref ref-type="bibr" rid="bib109">109</xref></sup> CyPA was found to localize in the infiltrating cells and/or in the extracellular matrix in the inflamed gingival connective tissues. Also, CyPA was involved in the inflammatory response of periodontal tissues through inducing the chemotaxis of PBMCs/neutrophils and the secretion of TNF<italic>&#x3B1;</italic>/IL-8.</p>
      <p>These data suggest that CyPA is associated with the inflammatory infiltration and alveolar bone destruction of periodontitis.</p>
    </sec>
    <sec>
      <title>CyPA and Aging</title>
      <p>Another interesting aspect of CyPA functions is its correlation with aging. Recently, Li <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib110">110</xref></sup> showed that the expression of CyPA increased with aging in normal skin, regardless of whether it was exposed or shaded. Similarly, it has been discovered that the expression level of CyPA is upregulated in the epidermis of aged people compared with younger people.<sup><xref ref-type="bibr" rid="bib111">111</xref></sup> Further, CyPA expression was found significantly higher in old rats than in the younger ones.<sup><xref ref-type="bibr" rid="bib112">112</xref></sup> In contrast, proteomic analysis of dermal fibroblasts cultured <italic>in vitro</italic> from human healthy subjects of different ages revealed that CyPA was markedly reduced with age, consistent with the reduced <italic>de novo</italic> synthesis of proteins and failure in performing biologically active conformational changes frequently observed during aging.<sup><xref ref-type="bibr" rid="bib113">113</xref></sup></p>
    </sec>
    <sec>
      <title>CyPA Inhibitors and Their Pharmacological Use</title>
      <p>As outlined above, CsA is a CyPA inhibitor and is the most well studied and tightest binding CyPA ligand identified to date.<sup><xref ref-type="bibr" rid="bib4">4</xref></sup> CsA binds both extracellular and intracellular CyPA and inhibits its PPIase activity. In particular, it inhibits the protein phosphatase calcineurin and blocks the translocation of nuclear factor from activated T cells (NF-AT) from the cytosol to the nucleus, thus preventing the transcription of genes encoding pro-inflammatory cytokines.<sup><xref ref-type="bibr" rid="bib114">114</xref>, <xref ref-type="bibr" rid="bib115">115</xref></sup></p>
      <p>Yurchenko <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib29">29</xref></sup> reported that CD147 interacts with extracellular CyPA in a CsA-sensitive fashion. Others showed that CsA blocks the folding of some proteins<sup><xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib10">10</xref></sup> and modulates protein trafficking in cells.<sup><xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib116">116</xref>, <xref ref-type="bibr" rid="bib117">117</xref></sup></p>
      <p>More importantly, CsA was shown by Borel <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib118">118</xref></sup> to be a potent and specific inhibitor of T-cell responses to alloantigens. This discovery led to widespread clinical use of CsA as an immunosuppressant, revolutionizing organ transplantation in humans. However, multiple side effects were observed with the long-term use of CsA in organ transplant recipients, especially severe nephrotoxicity, which remains one of the major obstacles for a broader use of the drug in the treatment of inflammation and other immune disorders.<sup><xref ref-type="bibr" rid="bib119">119</xref></sup></p>
      <p>Thus, compounds that selectively inhibit CyPA without immunosuppressive effects are urgently required and might be applicable to the therapy of human diseases. In this case, treatment with isoenzyme specific inhibitors (1) would probably elicit fewer side effects than a global CyP inhibitor like CsA and (2) would not get dispersed into a cellular sink when sequestered by other CyPs.</p>
      <p>Recently, scientists have synthesized derivatives of CsA that lack calcineurin-binding properties and thus do not exhibit immunosuppressive effects. The anti-inflammatory effect of these compounds is achieved because they directly block the pro-inflammatory and chemotactic functions of extracellular CyPA.</p>
      <p>A growing body of scientific evidence has indicated that these non-immunosuppressive analogs of CsA may have applications in multiple therapeutic areas. In particular, they are among the most promising of the new anti-HCV agents under development. For example, Alisporivir (Debio 025) is the first-in-class CyPA inhibitor that recently initiated a phase III trial. It binds to CyPA and shows additive anti-viral effect with pegylated interferon-alpha (pIFN-<italic>&#x3B1;</italic>) in patients with genotype 1 and 4 HCV.<sup><xref ref-type="bibr" rid="bib120">120</xref></sup></p>
      <p>In addition, another derivative of CsA, NIM811, has been shown to promise anti-inflammatory effects in different experimental models associated with inflammatory response, such as acute lung injury and arthritis.<sup><xref ref-type="bibr" rid="bib121">121</xref>, <xref ref-type="bibr" rid="bib122">122</xref></sup></p>
      <p>Another current challenge is to design therapeutic agents with the capacity to block specific functions of CyPA, while leaving other functions unaffected. In this context, a study reported the development of a small molecule with the capacity to specifically inhibit CyPA functions, without any effect on other CyP isoforms.<sup><xref ref-type="bibr" rid="bib123">123</xref></sup></p>
      <p>Recently, a potent CyPA inhibitor, MM218, which can selectively inhibit the extracellular fraction of CyPA, has been synthesized.<sup><xref ref-type="bibr" rid="bib124">124</xref></sup> It appears to have a stronger anti-inflammatory effect than CsA, as well as no detectable adverse effects in an animal model of acute lung injury<sup><xref ref-type="bibr" rid="bib125">125</xref></sup> and myocardial reperfusion injury.<sup><xref ref-type="bibr" rid="bib126">126</xref></sup></p>
      <p>It is hoped that the discovery of these novel selective drugs for CyPA might lead to a number of possible therapeutic applications in inflammatory disease.</p>
    </sec>
    <sec>
      <title>Conclusions and Perspectives</title>
      <p>Based on current knowledge reviewed above, it is now clear that CyPA has multi-functional properties. A number of biological studies demonstrated that CyPA is involved in various cellular functions including protein folding, trafficking, assembly, immune-modulation, and cell signaling.<sup><xref ref-type="bibr" rid="bib127">127</xref></sup></p>
      <p>In light of what is known about CyPA, it is believed that an increase in CyPA expression contributes to pathological conditions. In fact, CyPA<sup>&#x2212;/&#x2212;</sup> mice are protected from vascular remodeling,<sup><xref ref-type="bibr" rid="bib22">22</xref></sup> aortic aneurysm,<sup><xref ref-type="bibr" rid="bib32">32</xref></sup> atherosclerosis,<sup><xref ref-type="bibr" rid="bib36">36</xref></sup> cardiac hypertrophy,<sup><xref ref-type="bibr" rid="bib42">42</xref></sup> and ischemia/reperfusion injury.<sup><xref ref-type="bibr" rid="bib43">43</xref></sup> In addition, CyPA knockdown decreases tumor growth <italic>in vivo</italic><sup><xref ref-type="bibr" rid="bib72">72</xref>, <xref ref-type="bibr" rid="bib73">73</xref></sup> and CyPA inhibitors are the most promising of the new ant-HCV agents.<sup><xref ref-type="bibr" rid="bib120">120</xref></sup> Furthermore, several studies suggested that high CyPA expression correlates with poor outcome of patients with inflammatory diseases.<sup><xref ref-type="bibr" rid="bib92">92</xref>, <xref ref-type="bibr" rid="bib107">107</xref>, <xref ref-type="bibr" rid="bib128">128</xref></sup></p>
      <p>It is important to underline that both the intracellular and extracellular form of CyPA are involved in its pathogenic actions. Specifically, we found that, under inflammatory conditions, CyPA is secreted from cells and acts as an autocrine and paracrine factor that exacerbates oxidative stress and inflammation.<sup><xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib32">32</xref>, <xref ref-type="bibr" rid="bib42">42</xref></sup> However, extracellular CyPA has been found to have a biphasic effect, by promoting cell proliferation and migration at low doses and cytotoxic effects at higher doses.<sup><xref ref-type="bibr" rid="bib129">129</xref></sup></p>
      <p>The mechanism by which CyPA contributes to the development of inflammatory diseases may involve a complex interplay of proteins and pathways including the membrane receptor for CyPA, CD147. However, it is worth mentioning that a number of mechanistic details are still unknown and await further studies. Indeed, to date CD147 has not been proven unequivocally to mediate all of the cellular events associated with CyPA. Thus, the identification of novel receptors for CyPA would be essential for future translational efforts aimed at targeting the CyPA pathway.</p>
      <p>In conclusion, it is believed that the development of agents that selectively inactivate CyPA or that block binding of CyPA to its receptor could prove to be a fruitful approach to forestalling several human diseases.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors are supported by funding from the FP7-PEOPLE-2011-CIG-294016 and National Institutes of Health RF-2010-2321151.</p>
    </ack>
    <glossary>
      <def-list>
        <def-item>
          <term>EC</term>
          <def>
            <p>endothelial cells</p>
          </def>
        </def-item>
        <def-item>
          <term>VSMC</term>
          <def>
            <p>vascular smooth muscle cells</p>
          </def>
        </def-item>
        <def-item>
          <term>ROS</term>
          <def>
            <p>Reactive Oxygen Species</p>
          </def>
        </def-item>
        <def-item>
          <term>ERK1/2</term>
          <def>
            <p>Extracellular signal-regulated kinase 1/2</p>
          </def>
        </def-item>
        <def-item>
          <term>Ang II</term>
          <def>
            <p>angiotensin II</p>
          </def>
        </def-item>
        <def-item>
          <term>BM</term>
          <def>
            <p>bone marrow</p>
          </def>
        </def-item>
        <def-item>
          <term>LDL</term>
          <def>
            <p>l<italic>ow-density lipoprotein</italic></p>
          </def>
        </def-item>
        <def-item>
          <term>VCAM-1</term>
          <def>
            <p>vascular cell adhesion molecule 1</p>
          </def>
        </def-item>
        <def-item>
          <term>eNOS</term>
          <def>
            <p>endothelial nitric oxide synthase</p>
          </def>
        </def-item>
        <def-item>
          <term>KLF2</term>
          <def>
            <p>kruppel-like factor 2</p>
          </def>
        </def-item>
        <def-item>
          <term>TNF<italic>&#x3B1;</italic></term>
          <def>
            <p>tumor necrosis factor alpha</p>
          </def>
        </def-item>
        <def-item>
          <term>Vpr</term>
          <def>
            <p>viral protein R</p>
          </def>
        </def-item>
        <def-item>
          <term>IFN-I</term>
          <def>
            <p>interferon type I</p>
          </def>
        </def-item>
        <def-item>
          <term>M1</term>
          <def>
            <p>matrix protein 1</p>
          </def>
        </def-item>
        <def-item>
          <term>HRE</term>
          <def>
            <p>hypoxia response element</p>
          </def>
        </def-item>
        <def-item>
          <term>MMP</term>
          <def>
            <p>metalloproteinase</p>
          </def>
        </def-item>
        <def-item>
          <term>NS5A</term>
          <def>
            <p>non-structural 5A</p>
          </def>
        </def-item>
        <def-item>
          <term>IL</term>
          <def>
            <p>interleukin</p>
          </def>
        </def-item>
        <def-item>
          <term>MRP</term>
          <def>
            <p>multidrug resistance-associated protein</p>
          </def>
        </def-item>
        <def-item>
          <term>MGST1</term>
          <def>
            <p>microsomal glutathione <italic>S</italic>-transferase 1</p>
          </def>
        </def-item>
        <def-item>
          <term>GSTZ1</term>
          <def>
            <p>glutathione transferase zeta 1</p>
          </def>
        </def-item>
        <def-item>
          <term>ABC</term>
          <def>
            <p>ATP-binding cassette</p>
          </def>
        </def-item>
        <def-item>
          <term>AIF</term>
          <def>
            <p>apoptosis-inducing factor</p>
          </def>
        </def-item>
        <def-item>
          <term>SOD1</term>
          <def>
            <p>superoxide dismutase-1</p>
          </def>
        </def-item>
        <def-item>
          <term>NF-<italic>&#x3BA;</italic>B</term>
          <def>
            <p>nuclear factor kappa B</p>
          </def>
        </def-item>
        <def-item>
          <term>NF-AT</term>
          <def>
            <p>nuclear factor from activated T cells</p>
          </def>
        </def-item>
        <def-item>
          <term>pIFN-<italic>&#x3B1;</italic></term>
          <def>
            <p>pegylated interferon-alpha</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>Edited by G Melino</p>
      </fn>
    </fn-group>
    <notes>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <ref id="bib1">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Heitman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The cyclophilins</article-title>
          <source>Genome Biol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>226</fpage>
          <pub-id pub-id-type="pmid">15998457</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib2">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
              <given-names>FX</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Catalysis of protein folding by prolyl isomerase</article-title>
          <source>Nature</source>
          <year>1987</year>
          <volume>329</volume>
          <fpage>268</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">3306408</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib3">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dornan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Walkinshaw</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Structures of immunophilins and their ligand complexes</article-title>
          <source>Curr Top Med Chem</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>1392</fpage>
          <lpage>1409</lpage>
          <pub-id pub-id-type="pmid">12871171</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib4">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Handschumacher</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Harding</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Drugge</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Speicher</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin: a specific cytosolic binding protein for cyclosporin A</article-title>
          <source>Science</source>
          <year>1984</year>
          <volume>226</volume>
          <fpage>544</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="pmid">6238408</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib5">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luban</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions</article-title>
          <source>Cell</source>
          <year>1996</year>
          <volume>87</volume>
          <fpage>1157</fpage>
          <lpage>1159</lpage>
          <pub-id pub-id-type="pmid">8980222</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib6">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bosco</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Eisenmesser</surname>
              <given-names>EZ</given-names>
            </name>
            <name>
              <surname>Pochapsky</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sundquist</surname>
              <given-names>WI</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>5247</fpage>
          <lpage>5252</lpage>
          <pub-id pub-id-type="pmid">11929983</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib7">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helekar</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Char</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Neff</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Patrick</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Prolyl isomerase requirement for the expression of functional homo-oligomeric ligand-gated ion channels</article-title>
          <source>Neuron</source>
          <year>1994</year>
          <volume>12</volume>
          <fpage>179</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="pmid">7507339</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib8">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helekar</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Patrick</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>5432</fpage>
          <lpage>5437</lpage>
          <pub-id pub-id-type="pmid">9144255</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib9">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steinmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bruckner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Superti-Furga</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase</article-title>
          <source>J Biol Chem</source>
          <year>1991</year>
          <volume>266</volume>
          <fpage>1299</fpage>
          <lpage>1303</lpage>
          <pub-id pub-id-type="pmid">1985948</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib10">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lodish</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum</article-title>
          <source>J Biol Chem</source>
          <year>1991</year>
          <volume>266</volume>
          <fpage>14835</fpage>
          <lpage>14838</lpage>
          <pub-id pub-id-type="pmid">1714445</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib11">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shieh</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Stamnes</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Seavello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Zuker</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>The ninaA gene required for visual transduction in <italic>Drosophila</italic> encodes a homologue of cyclosporin A-binding protein</article-title>
          <source>Nature</source>
          <year>1989</year>
          <volume>338</volume>
          <fpage>67</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">2493138</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib12">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneuwly</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shortridge</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Larrivee</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Ono</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ozaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pak</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title><italic>Drosophila ninaA</italic> gene encodes an eye-specific cyclophilin (cyclosporine A binding protein)</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1989</year>
          <volume>86</volume>
          <fpage>5390</fpage>
          <lpage>5394</lpage>
          <pub-id pub-id-type="pmid">2664782</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib13">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Deinum</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Modjtahedi</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia</article-title>
          <source>J Exp Med</source>
          <year>2007</year>
          <volume>204</volume>
          <fpage>1741</fpage>
          <lpage>1748</lpage>
          <pub-id pub-id-type="pmid">17635954</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib14">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Izuta</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsuruma</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shimazawa</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apoptosis-inducing factor and cyclophilin A cotranslocate to the motor neuronal nuclei in amyotrophic lateral sclerosis model mice</article-title>
          <source>CNS Neurosci Ther</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>294</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">20553309</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib15">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Qiao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mines</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration</article-title>
          <source>J Biol Chem</source>
          <year>2008</year>
          <volume>283</volume>
          <fpage>623</fpage>
          <lpage>637</lpage>
          <pub-id pub-id-type="pmid">17991743</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib16">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yurchenko</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pushkarsky</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Sherry</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bukrinsky</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>17013</fpage>
          <lpage>17019</lpage>
          <pub-id pub-id-type="pmid">15671024</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib17">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wolkoff</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Stockert</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Phosphorylation-dependent interaction of the asialoglycoprotein receptor with molecular chaperones</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>37798</fpage>
          <lpage>37803</lpage>
          <pub-id pub-id-type="pmid">12167617</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib18">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A mediates Vid22p function in the import of fructose-1,6-bisphosphatase into Vid vesicles</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>48017</fpage>
          <lpage>48026</lpage>
          <pub-id pub-id-type="pmid">11641409</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib19">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ansari</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Greco</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Luban</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export</article-title>
          <source>Mol Cell Biol</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>6993</fpage>
          <lpage>7003</lpage>
          <pub-id pub-id-type="pmid">12242280</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib20">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colgan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Asmal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Luban</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine</article-title>
          <source>J Immunol</source>
          <year>2005</year>
          <volume>174</volume>
          <fpage>6030</fpage>
          <lpage>6038</lpage>
          <pub-id pub-id-type="pmid">15879096</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib21">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Melaragno</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Haendeler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Suh</surname>
              <given-names>YA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A is a secreted growth factor induced by oxidative stress</article-title>
          <source>Circ Res</source>
          <year>2000</year>
          <volume>87</volume>
          <fpage>789</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="pmid">11055983</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib22">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matoba</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>O'Dell</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Nigro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation</article-title>
          <source>Circulation</source>
          <year>2008</year>
          <volume>117</volume>
          <fpage>3088</fpage>
          <lpage>3098</lpage>
          <pub-id pub-id-type="pmid">18541741</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib23">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Lungu</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Berk</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A is a proinflammatory cytokine that activates endothelial cells</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>1186</fpage>
          <lpage>1191</lpage>
          <pub-id pub-id-type="pmid">15130913</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib24">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seko</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fujimura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Taka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mineki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Murayama</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2004</year>
          <volume>317</volume>
          <fpage>162</fpage>
          <lpage>168</lpage>
          <pub-id pub-id-type="pmid">15047162</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib25">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sherry</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Yarlett</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Strupp</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cerami</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1992</year>
          <volume>89</volume>
          <fpage>3511</fpage>
          <lpage>3515</lpage>
          <pub-id pub-id-type="pmid">1565646</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib26">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suzuki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Meoli</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Matoba</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Berk</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells</article-title>
          <source>Circ Res</source>
          <year>2006</year>
          <volume>98</volume>
          <fpage>811</fpage>
          <lpage>817</lpage>
          <pub-id pub-id-type="pmid">16527992</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib27">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mittal</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Voldman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Nonmitogenic survival-enhancing autocrine factors including cyclophilin A contribute to density-dependent mouse embryonic stem cell growth</article-title>
          <source>Stem Cell Res</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>168</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="pmid">21112823</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib28">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Leiva</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Fischkoff</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Handschumacher</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Lyttle</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Leukocyte chemotactic activity of cyclophilin</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>11968</fpage>
          <lpage>11971</lpage>
          <pub-id pub-id-type="pmid">1601866</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib29">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yurchenko</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Zybarth</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>O'Connor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Franchin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Active site residues of cyclophilin A are crucial for its signaling activity via CD147</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>22959</fpage>
          <lpage>22965</lpage>
          <pub-id pub-id-type="pmid">11943775</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib30">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nigro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Berk</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A</article-title>
          <source>Antioxid Redox Signal</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>675</fpage>
          <lpage>682</lpage>
          <pub-id pub-id-type="pmid">19747062</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib31">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobrin</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Baumgartner</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Anidjar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chejfec</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mrkvicka</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1996</year>
          <volume>800</volume>
          <fpage>74</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">8958984</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib32">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nigro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Matoba</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>O'Dell</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms</article-title>
          <source>Nat Med</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>649</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="pmid">19430489</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib33">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prins</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Perati</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Kon</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Ramesh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Linton</surname>
              <given-names>MF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Benzo[a]pyrene potentiates the pathogenesis of abdominal aortic aneurysms in apolipoprotein E knockout mice</article-title>
          <source>Cell Physiol Biochem</source>
          <year>2012</year>
          <volume>29</volume>
          <fpage>121</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">22415081</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib34">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piechota-Polanczyk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Demyanets</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nykonenko</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Huk</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mittlboeck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Domenig</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Decreased tissue levels of cyclophilin A, a cyclosporine A target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm</article-title>
          <source>Eur J Vasc Endovasc Surg</source>
          <year>2013</year>
          <volume>45</volume>
          <fpage>682</fpage>
          <lpage>688</lpage>
          <pub-id pub-id-type="pmid">23558220</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib35">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golledge</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Norman</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <article-title>Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>1075</fpage>
          <lpage>1077</lpage>
          <pub-id pub-id-type="pmid">20484703</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib36">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nigro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Satoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>O'Dell</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Soe</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice</article-title>
          <source>J Exp Med</source>
          <year>2011</year>
          <volume>208</volume>
          <fpage>53</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">21173104</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib37">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rezzani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Favero</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stacchiotti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rodella</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>Endothelial and vascular smooth muscle cell dysfunction mediated by cyclophylin A and the atheroprotective effects of melatonin</article-title>
          <source>Life Sci</source>
          <year>2013</year>
          <volume>92</volume>
          <fpage>875</fpage>
          <lpage>882</lpage>
          <pub-id pub-id-type="pmid">23201430</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib38">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seizer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schonberger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schott</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Bigalke</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation</article-title>
          <source>Atherosclerosis</source>
          <year>2010</year>
          <volume>209</volume>
          <fpage>51</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">19758589</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib39">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coppinger</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cagney</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Toomey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kislinger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Belton</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>McRedmond</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <fpage>2096</fpage>
          <lpage>2104</lpage>
          <pub-id pub-id-type="pmid">14630798</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib40">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elvers</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Herrmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seizer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Munzer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schonberger</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <fpage>1317</fpage>
          <lpage>1326</lpage>
          <pub-id pub-id-type="pmid">22740452</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib41">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Griendling</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>FitzGerald</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and cardiovascular injury: part I: basic mechanisms and <italic>in vivo</italic> monitoring of ROS</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>108</volume>
          <fpage>1912</fpage>
          <lpage>1916</lpage>
          <pub-id pub-id-type="pmid">14568884</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib42">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nigro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zeidan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Soe</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Jaffre</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oikawa</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>1116</fpage>
          <lpage>1123</lpage>
          <pub-id pub-id-type="pmid">21330604</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib43">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seizer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ochmann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schonberger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Borst</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <year>2012</year>
          <volume>31</volume>
          <fpage>1377</fpage>
          <lpage>1386</lpage>
          <pub-id pub-id-type="pmid">21441138</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib44">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The clinical implications of increased cyclophilin A levels in patients with acute coronary syndromes</article-title>
          <source>Clin Chim Acta</source>
          <year>2012</year>
          <volume>413</volume>
          <fpage>691</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="pmid">22209965</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib45">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fukumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sugimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nochioka</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Plasma cyclophilin A is a novel biomarker for coronary artery disease</article-title>
          <source>Circ J</source>
          <year>2013</year>
          <volume>77</volume>
          <fpage>447</fpage>
          <lpage>455</lpage>
          <pub-id pub-id-type="pmid">23138189</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib46">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramachandran</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Venugopal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sathisha</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Reshmi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Charles</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Divya</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes</article-title>
          <source>Proteomics</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>2808</fpage>
          <lpage>2821</lpage>
          <pub-id pub-id-type="pmid">22930659</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib47">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>An</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Hutcheson-Dilks</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Donfield</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goedert</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS</article-title>
          <source>PLoS Pathog</source>
          <year>2007</year>
          <volume>3</volume>
          <fpage>e88</fpage>
          <pub-id pub-id-type="pmid">17590083</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib48">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Endrich</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Gehring</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood</article-title>
          <source>Eur J Biochem</source>
          <year>1998</year>
          <volume>252</volume>
          <fpage>441</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">9546659</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib49">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braaten</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Luban</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells</article-title>
          <source>EMBO J</source>
          <year>2001</year>
          <volume>20</volume>
          <fpage>1300</fpage>
          <lpage>1309</lpage>
          <pub-id pub-id-type="pmid">11250896</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib50">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zander</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sherman</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Tessmer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bruns</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wray</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Prechtel</surname>
              <given-names>AT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>43202</fpage>
          <lpage>43213</lpage>
          <pub-id pub-id-type="pmid">12881522</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib51">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aiken</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Nef enhances HIV-1 infectivity via association with the virus assembly complex</article-title>
          <source>Virology</source>
          <year>2008</year>
          <volume>373</volume>
          <fpage>287</fpage>
          <lpage>297</lpage>
          <pub-id pub-id-type="pmid">18191978</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib52">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hogstad</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Unutmaz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Littman</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>467</volume>
          <fpage>214</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="pmid">20829794</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib53">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patient</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hourioux</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sizaret</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Trassard</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sureau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roingeard</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking</article-title>
          <source>J Virol</source>
          <year>2007</year>
          <volume>81</volume>
          <fpage>3842</fpage>
          <lpage>3851</lpage>
          <pub-id pub-id-type="pmid">17267490</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib54">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chatterji</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bobardt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Selvarajah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sakamoto</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The isomerase active site of cyclophilin A is critical for hepatitis C virus replication</article-title>
          <source>J Biol Chem</source>
          <year>2009</year>
          <volume>284</volume>
          <fpage>16998</fpage>
          <lpage>17005</lpage>
          <pub-id pub-id-type="pmid">19380579</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib55">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tellinghuisen</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Foss</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Treadaway</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein</article-title>
          <source>J Virol</source>
          <year>2008</year>
          <volume>82</volume>
          <fpage>1073</fpage>
          <lpage>1083</lpage>
          <pub-id pub-id-type="pmid">18032500</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib56">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>She</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection</article-title>
          <source>J Virol</source>
          <year>2010</year>
          <volume>84</volume>
          <fpage>3373</fpage>
          <lpage>3381</lpage>
          <pub-id pub-id-type="pmid">20089655</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib57">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaw</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Colangelo</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Gulcicek</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Palese</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cellular proteins in influenza virus particles</article-title>
          <source>PLoS Pathog</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>e1000085</fpage>
          <pub-id pub-id-type="pmid">18535660</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib58">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells</article-title>
          <source>Proteomics</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>1851</fpage>
          <lpage>1858</lpage>
          <pub-id pub-id-type="pmid">18398875</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib59">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>Q</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication</article-title>
          <source>Cell Microbiol</source>
          <year>2009</year>
          <volume>11</volume>
          <fpage>730</fpage>
          <lpage>741</lpage>
          <pub-id pub-id-type="pmid">19207730</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib60">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castro</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Moussatche</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Damaso</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles</article-title>
          <source>J Virol</source>
          <year>2003</year>
          <volume>77</volume>
          <fpage>9052</fpage>
          <lpage>9068</lpage>
          <pub-id pub-id-type="pmid">12885921</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib61">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bose</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mathur</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype</article-title>
          <source>J Gen Virol</source>
          <year>2003</year>
          <volume>84</volume>
          <supplement>(Pt 7</supplement>
          <fpage>1687</fpage>
          <lpage>1699</lpage>
          <pub-id pub-id-type="pmid">12810862</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib62">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gui</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2004</year>
          <volume>321</volume>
          <fpage>557</fpage>
          <lpage>565</lpage>
          <pub-id pub-id-type="pmid">15358143</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib63">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A inhibits rotavirus replication by facilitating host IFN-I production</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2012</year>
          <volume>422</volume>
          <fpage>664</fpage>
          <lpage>669</lpage>
          <pub-id pub-id-type="pmid">22609402</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib64">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keyes</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Bego</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Soland</surname>
              <given-names>M</given-names>
              <suffix>St</suffix>
            </name>
            <name>
              <surname>Jeor</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation</article-title>
          <source>J Gen Virol</source>
          <year>2012</year>
          <volume>93</volume>
          <supplement>(Pt 4</supplement>
          <fpage>722</fpage>
          <lpage>732</lpage>
          <pub-id pub-id-type="pmid">22238232</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib65">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoerauf</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rascher</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pahl</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Solbach</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Brune</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Host-cell cyclophilin is important for the intracellular replication of Leishmania major</article-title>
          <source>Mol Microbiol</source>
          <year>1997</year>
          <volume>24</volume>
          <fpage>421</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="pmid">9159527</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib66">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berriman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fairlamb</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Detailed characterization of a cyclophilin from the human malaria parasite Plasmodium falciparum</article-title>
          <source>Biochem J</source>
          <year>1998</year>
          <volume>334</volume>
          <supplement>(Pt 2</supplement>
          <fpage>437</fpage>
          <lpage>445</lpage>
          <pub-id pub-id-type="pmid">9716503</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib67">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golding</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aliberti</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Manischewitz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Valenzuela</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii</article-title>
          <source>Blood</source>
          <year>2003</year>
          <volume>102</volume>
          <fpage>3280</fpage>
          <lpage>3286</lpage>
          <pub-id pub-id-type="pmid">12855560</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib68">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Monaghan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action</article-title>
          <source>Int J Parasitol</source>
          <year>2006</year>
          <volume>36</volume>
          <fpage>261</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="pmid">16443228</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib69">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dutta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Delhi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sinha</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Datta</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Lack of abundance of cytoplasmic cyclosporin A-binding protein renders free-living <italic>Leishmania donovani</italic> resistant to cyclosporin A</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>19294</fpage>
          <lpage>19300</lpage>
          <pub-id pub-id-type="pmid">11278494</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib70">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Qiao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2007</year>
          <volume>361</volume>
          <fpage>763</fpage>
          <lpage>767</lpage>
          <pub-id pub-id-type="pmid">17678621</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib71">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qi</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>QY</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>YW</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma</article-title>
          <source>J Cell Biochem</source>
          <year>2008</year>
          <volume>104</volume>
          <fpage>1625</fpage>
          <lpage>1635</lpage>
          <pub-id pub-id-type="pmid">18320592</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib72">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Howard</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Furumai</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Campa</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Rabbani</surname>
              <given-names>ZN</given-names>
            </name>
            <name>
              <surname>Vujaskovic</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>XF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth <italic>in vivo</italic></article-title>
          <source>Cancer Res</source>
          <year>2005</year>
          <volume>65</volume>
          <fpage>8853</fpage>
          <lpage>8860</lpage>
          <pub-id pub-id-type="pmid">16204056</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib73">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma</article-title>
          <source>Mol Cell Proteomics</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>1810</fpage>
          <lpage>1823</lpage>
          <pub-id pub-id-type="pmid">18421009</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib74">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Semba</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Huebner</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression</article-title>
          <source>Mol Cancer Res</source>
          <year>2006</year>
          <volume>4</volume>
          <fpage>529</fpage>
          <lpage>538</lpage>
          <pub-id pub-id-type="pmid">16885564</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib75">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Piao</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Ha</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Choe</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death</article-title>
          <source>Cancer Res</source>
          <year>2007</year>
          <volume>67</volume>
          <fpage>3654</fpage>
          <lpage>3662</lpage>
          <pub-id pub-id-type="pmid">17440077</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib76">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calhoun</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chiu</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Knockdown endogenous CypA with siRNA in U2OS cells results in disruption of F-actin structure and alters tumor phenotype</article-title>
          <source>Mol Cell Biochem</source>
          <year>2009</year>
          <volume>320</volume>
          <fpage>35</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">18704644</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib77">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cecconi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Astner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Donadelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Palmieri</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Missiaglia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hamdan</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine</article-title>
          <source>Electrophoresis</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>4291</fpage>
          <lpage>4303</lpage>
          <pub-id pub-id-type="pmid">14679576</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib78">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fatima</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Stauffer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Smythers</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Greenwald</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells</article-title>
          <source>Cancer Epidemiol Biomarkers Prev</source>
          <year>2006</year>
          <volume>15</volume>
          <fpage>1598</fpage>
          <lpage>1606</lpage>
          <pub-id pub-id-type="pmid">16985019</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib79">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>VW</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Hui</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry</article-title>
          <source>Oncol Rep</source>
          <year>2008</year>
          <volume>20</volume>
          <fpage>89</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">18575723</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib80">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclosporin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells</article-title>
          <source>Oncol Rep</source>
          <year>2010</year>
          <volume>23</volume>
          <fpage>1053</fpage>
          <lpage>1062</lpage>
          <pub-id pub-id-type="pmid">20204291</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib81">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>The regulation of exosome secretion: a novel function of the p53 protein</article-title>
          <source>Cancer Res</source>
          <year>2006</year>
          <volume>66</volume>
          <fpage>4795</fpage>
          <lpage>4801</lpage>
          <pub-id pub-id-type="pmid">16651434</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib82">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Saiyin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance</article-title>
          <source>Cancer Chemother Pharmacol</source>
          <year>2008</year>
          <volume>61</volume>
          <fpage>459</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="pmid">17520256</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib83">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blackburn</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Coggan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tzeng</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Lantum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Polekhina</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>MW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GSTZ1d: a new allele of glutathione transferase zeta and maleylacetoacetate isomerase</article-title>
          <source>Pharmacogenetics</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>671</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="pmid">11692075</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib84">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Monteiro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Cerqueira</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>El-Bacha</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives</article-title>
          <source>Oxid Med Cell Longev</source>
          <year>2011</year>
          <volume>2011</volume>
          <fpage>467180</fpage>
          <pub-id pub-id-type="pmid">22191013</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib85">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bell</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Winkler</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sagare</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Deane</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apolipoprotein E controls cerebrovascular integrity via cyclophilin A</article-title>
          <source>Nature</source>
          <year>2012</year>
          <volume>485</volume>
          <fpage>512</fpage>
          <lpage>516</lpage>
          <pub-id pub-id-type="pmid">22622580</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib86">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanyenda</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Verdile</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Boulos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Krishnaswamy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Taddei</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Meloni</surname>
              <given-names>BP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The dynamics of CD147 in Alzheimer's disease development and pathology</article-title>
          <source>J Alzheimers Dis</source>
          <year>2011</year>
          <volume>26</volume>
          <fpage>593</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="pmid">21694447</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib87">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spisni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Valerii</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Manerba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Strillacci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Polazzi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mattia</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons</article-title>
          <source>Neurotoxicology</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>605</fpage>
          <lpage>612</lpage>
          <pub-id pub-id-type="pmid">19635393</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib88">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cookson</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Menzies</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Manning</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Eggett</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Figlewicz</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>McNeil</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress</article-title>
          <source>Amyotroph Lateral Scler Other Motor Neuron Disord</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>75</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">12215229</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib89">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Massignan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Casoni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stefanazzi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Biasini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tortarolo</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2007</year>
          <volume>353</volume>
          <fpage>719</fpage>
          <lpage>725</lpage>
          <pub-id pub-id-type="pmid">17196550</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib90">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Palfrey</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Bindokas</surname>
              <given-names>VP</given-names>
            </name>
            <name>
              <surname>Ghadge</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>RJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The role of immunophilins in mutant superoxide dismutase-1linked familial amyotrophic lateral sclerosis</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>3251</fpage>
          <lpage>3256</lpage>
          <pub-id pub-id-type="pmid">10077670</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib91">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basso</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Samengo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nardo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Massignan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>D'Alessandro</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tartari</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis</article-title>
          <source>PLoS One</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>e8130</fpage>
          <pub-id pub-id-type="pmid">19956584</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib92">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nardo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pozzi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pignataro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lauranzano</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Spano</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Garbelli</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e25545</fpage>
          <pub-id pub-id-type="pmid">21998667</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib93">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Billich</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Winkler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aschauer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rot</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peichl</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis</article-title>
          <source>J Exp Med</source>
          <year>1997</year>
          <volume>185</volume>
          <fpage>975</fpage>
          <lpage>980</lpage>
          <pub-id pub-id-type="pmid">9120404</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib94">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Jeon</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Cha</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Ahn</surname>
              <given-names>KS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages</article-title>
          <source>Clin Immunol</source>
          <year>2005</year>
          <volume>116</volume>
          <fpage>217</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="pmid">15993649</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib95">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>ZN</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signaling pathway in rheumatoid arthritis</article-title>
          <source>Rheumatology (Oxford)</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>1299</fpage>
          <lpage>1310</lpage>
          <pub-id pub-id-type="pmid">18567920</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib96">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>XK</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>HB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis</article-title>
          <source>J Clin Immunol</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>24</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">19789967</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib97">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>ZH</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes</article-title>
          <source>J Cell Mol Med</source>
          <year>2011</year>
          <volume>15</volume>
          <fpage>850</fpage>
          <lpage>860</lpage>
          <pub-id pub-id-type="pmid">20455995</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib98">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>[The role of CyPA in chemotaxis of neutrophil in rheumatoid arthritis and secretion of interleukin-8]</article-title>
          <source>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>423</fpage>
          <lpage>425</lpage>
          <pub-id pub-id-type="pmid">19426598</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib99">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tegeder</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schumacher</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Geiger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Geisslinger</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bang</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Elevated serum cyclophilin levels in patients with severe sepsis</article-title>
          <source>J Clin Immunol</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>380</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">9327337</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib100">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dear</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Leelahavanichkul</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aponte</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Constant</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Hewitt</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure</article-title>
          <source>Crit Care Med</source>
          <year>2007</year>
          <volume>35</volume>
          <fpage>2319</fpage>
          <lpage>2328</lpage>
          <pub-id pub-id-type="pmid">17944020</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib101">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeng</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>XY</given-names>
            </name>
          </person-group>
          <article-title>[Proteomic study of peripheral blood lymphocytes of rabbits with severe burn and <italic>Pseudomonas aeruginosa</italic> sepsis]</article-title>
          <source>Zhongguo Wei Zhong Bing Ji Jiu Yi Xue</source>
          <year>2009</year>
          <volume>21</volume>
          <fpage>455</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="pmid">19695163</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib102">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>PF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic change of peripheral lymphocytes from scald injury and <italic>Pseudomonas aeruginosa</italic> sepsis in rabbits</article-title>
          <source>Burns</source>
          <year>2010</year>
          <volume>36</volume>
          <fpage>82</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">19857930</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib103">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>XY</given-names>
            </name>
          </person-group>
          <article-title>[Proteomic change in lymphocytes of scalded rabbits caused by <italic>Staphylococcus aureus</italic> invasion]</article-title>
          <source>Zhonghua Shao Shang Za Zhi</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>202</fpage>
          <lpage>206</lpage>
          <pub-id pub-id-type="pmid">19842557</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib104">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeng</surname>
              <given-names>RZ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>MY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Protein expression changes in human monocytic THP-1 cells treated with lipoteichoic acid from <italic>Lactobacillus plantarum</italic> and <italic>Staphylococcus aureus</italic></article-title>
          <source>Mol Cells</source>
          <year>2010</year>
          <volume>29</volume>
          <fpage>585</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="pmid">20496118</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib105">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gwinn</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Damsker</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Falahati</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Okwumabua</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kelly-Welch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Keegan</surname>
              <given-names>AD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention</article-title>
          <source>J Immunol</source>
          <year>2006</year>
          <volume>177</volume>
          <fpage>4870</fpage>
          <lpage>4879</lpage>
          <pub-id pub-id-type="pmid">16982929</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib106">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stemmy</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Balsley</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Jurjus</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Damsker</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Bukrinsky</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Constant</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2011</year>
          <volume>45</volume>
          <fpage>991</fpage>
          <lpage>998</lpage>
          <pub-id pub-id-type="pmid">21493785</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib107">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stemmy</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Benton</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Lerner</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Alcala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Constant</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Freishtat</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Extracellular cyclophilin levels associate with parameters of asthma in phenotypic clusters</article-title>
          <source>J Asthma</source>
          <year>2011</year>
          <volume>48</volume>
          <fpage>986</fpage>
          <lpage>993</lpage>
          <pub-id pub-id-type="pmid">21999750</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib108">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xiang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Cyclophilin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>(CypA) is associated with the inflammatory infiltration and alveolar bone destruction in an experimental periodontitis</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2010</year>
          <volume>391</volume>
          <fpage>1000</fpage>
          <lpage>1006</lpage>
          <pub-id pub-id-type="pmid">19968957</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib109">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xiang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Over-expression and potential role of cyclophilin A in human periodontitis</article-title>
          <source>J Periodontal Res</source>
          <year>2013</year>
          <volume>48</volume>
          <fpage>615</fpage>
          <lpage>622</lpage>
          <pub-id pub-id-type="pmid">23441725</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib110">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lei</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of cyclophilin A and CD147 during skin aging</article-title>
          <source>Zhong Nan Da Xue Xue Bao Yi Xue Ban</source>
          <year>2011</year>
          <volume>36</volume>
          <fpage>203</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="pmid">21464540</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib111">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gromov</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Skovgaard</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Palsdottir</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gromova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ostergaard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Celis</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon-gamma-induced polypeptides that includes manganese-superoxide dismutase and the p85beta subunit of phosphatidylinositol 3-kinase</article-title>
          <source>Mol Cell Proteomics</source>
          <year>2003</year>
          <volume>2</volume>
          <fpage>70</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">12644569</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib112">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rider</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Identification of valid housekeeping genes and antioxidant enzyme gene expression change in the aging rat liver</article-title>
          <source>J Gerontol A Biol Sci Med Sci</source>
          <year>2006</year>
          <volume>61</volume>
          <fpage>20</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">16456191</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib113">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boraldi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liberatori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Armini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pallini</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Tiozzo</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteome analysis of dermal fibroblasts cultured <italic>in vitro</italic> from human healthy subjects of different ages</article-title>
          <source>Proteomics</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>917</fpage>
          <lpage>929</lpage>
          <pub-id pub-id-type="pmid">12833515</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib114">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emmel</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Verweij</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Durand</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Lacy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Crabtree</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation</article-title>
          <source>Science</source>
          <year>1989</year>
          <volume>246</volume>
          <fpage>1617</fpage>
          <lpage>1620</lpage>
          <pub-id pub-id-type="pmid">2595372</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib115">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flanagan</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Corthesy</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bram</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Crabtree</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A</article-title>
          <source>Nature</source>
          <year>1991</year>
          <volume>352</volume>
          <fpage>803</fpage>
          <lpage>807</lpage>
          <pub-id pub-id-type="pmid">1715516</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib116">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiraishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yokoo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yanagita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Uezono</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Minami</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells</article-title>
          <source>Neurosci Lett</source>
          <year>2000</year>
          <volume>293</volume>
          <fpage>211</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="pmid">11036198</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib117">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chklovskaia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nissen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Landmann</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rahner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Wodnar-Filipowicz</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A</article-title>
          <source>Blood</source>
          <year>2001</year>
          <volume>97</volume>
          <fpage>1027</fpage>
          <lpage>1034</lpage>
          <pub-id pub-id-type="pmid">11159533</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib118">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borel</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Feurer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Magnee</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stahelin</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Effects of the new anti-lymphocytic peptide cyclosporin A in animals</article-title>
          <source>Immunology</source>
          <year>1977</year>
          <volume>32</volume>
          <fpage>1017</fpage>
          <lpage>1025</lpage>
          <pub-id pub-id-type="pmid">328380</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib119">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stahelin</surname>
              <given-names>HF</given-names>
            </name>
          </person-group>
          <article-title>The history of cyclosporin A (Sandimmune) revisited: another point of view</article-title>
          <source>Experientia</source>
          <year>1996</year>
          <volume>52</volume>
          <fpage>5</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">8575558</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib120">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flisiak</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Feinman</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Jablkowski</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Horban</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kryczka</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Pawlowska</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naive hepatitis C patients</article-title>
          <source>Hepatology</source>
          <year>2009</year>
          <volume>49</volume>
          <fpage>1460</fpage>
          <lpage>1468</lpage>
          <pub-id pub-id-type="pmid">19353740</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib121">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arora</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gwinn</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Bower</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Okwumabua</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>HR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular cyclophilins contribute to the regulation of inflammatory responses</article-title>
          <source>J Immunol</source>
          <year>2005</year>
          <volume>175</volume>
          <fpage>517</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="pmid">15972687</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib122">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Damsker</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Okwumabua</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pushkarsky</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arora</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bukrinsky</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Constant</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Targeting the chemotactic function of CD147 reduces collagen-induced arthritis</article-title>
          <source>Immunology</source>
          <year>2009</year>
          <volume>126</volume>
          <fpage>55</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">18557953</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib123">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Itami</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yanagi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tatara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takamiya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors</article-title>
          <source>J Biomol Screen</source>
          <year>2009</year>
          <volume>14</volume>
          <fpage>419</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="pmid">19403925</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib124">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malesevic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuhling</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Erdmann</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Balsley</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bukrinsky</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Constant</surname>
              <given-names>SL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A cyclosporin derivative discriminates between extracellular and intracellular cyclophilins. Angew Chem</article-title>
          <source>Int Ed Engl</source>
          <year>2010</year>
          <volume>49</volume>
          <fpage>213</fpage>
          <lpage>215</lpage>
        </mixed-citation>
      </ref>
      <ref id="bib125">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balsley</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Malesevic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stemmy</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Gigley</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jurjus</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation</article-title>
          <source>J Immunol</source>
          <year>2010</year>
          <volume>185</volume>
          <fpage>7663</fpage>
          <lpage>7670</lpage>
          <pub-id pub-id-type="pmid">21057089</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib126">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracellular cyclophilin A may be a potential target to protect against myocardial reperfusion injury</article-title>
          <source>Med Hypotheses</source>
          <year>2011</year>
          <volume>77</volume>
          <fpage>734</fpage>
          <lpage>738</lpage>
          <pub-id pub-id-type="pmid">21824732</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib127">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galat</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Peptidylproline cis-trans-isomerases: immunophilins</article-title>
          <source>Eur J Biochem</source>
          <year>1993</year>
          <volume>216</volume>
          <fpage>689</fpage>
          <lpage>707</lpage>
          <pub-id pub-id-type="pmid">8404888</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib128">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Obchoei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wongkhan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wongkham</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>potential functions and therapeutic target for human cancer</article-title>
          <source>Med Sci Monit</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>RA221</fpage>
          <lpage>RA232</lpage>
          <pub-id pub-id-type="pmid">19865066</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib129">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Lessner</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sakurai</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Galis</surname>
              <given-names>ZS</given-names>
            </name>
          </person-group>
          <article-title>Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction</article-title>
          <source>Am J Pathol</source>
          <year>2004</year>
          <volume>164</volume>
          <fpage>1567</fpage>
          <lpage>1574</lpage>
          <pub-id pub-id-type="pmid">15111303</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>CyPA is involved in AAA formation. Ang II induces ROS formation; this in turn determines the release of CyPA from VSMC. Extracellular CyPA contributes to the recruitment of inflammatory cells in the aneurysm site and the activation of MMPs that degrade the extracellular matrix. CyPA itself induces ROS formation by a positive feedback loop</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013410f1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>CyPA contributes to atherosclerosis formation. As atherosclerosis progresses, inflammation and ROS induce the release of CyPA from VSMC, EC and macrophages. Intracellular CyPA, as well as extracellular CyPA, influence LDL uptake by regulating the expression of scavenger receptors on the vessel wall. Also, CyPA induces inflammation of EC by increasing adhesion molecule expression and decreasing eNOS expression. In addition, CyPA increases the apoptosis of EC. Finally, CyPA induces the recruitment of inflammatory cells in atherosclerotic lesions</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013410f2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>CyPA effects on EC, VSMC and macrophages. CyPA is secreted in response to ROS. Extracellular CyPA increases DNA synthesis and inhibits apoptosis in VSMC. In contrast, CyPA stimulates EC apoptosis, stimulates the expression of adhesion molecules including E-selectin and VCAM-1. Also, extracellular CyPA induces a pro-inflammatory status in macrophages by stimulating cytokines and chemokines production as well as inducing the activation of MMP-9 and decreasing apoptosis. These effects induce inflammation, EC dysfunction, neointimal formation thereby accelerating vascular remodeling, AAA and atherosclerosis</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013410f3"/>
    </fig>
    <fig id="fig4">
      <label>Figure 4</label>
      <caption>
        <p>CyPA induces cancer growth. Apoptosis and hypoxia, through the activation of p53 and HIF1<italic>&#x3B1;</italic>, upregulate CyPA expression. This in turn stabilizes p53 protein. CyPA is also secreted by cancer cells and promotes cancer growth, metastasis and drug resistance. Anti-cancer drugs, such as DAC and 5-FU, decrease CyPA expression and thus block cancer progression. However, CyPA upregulation also decreases cisplatin-induced cell death suggesting that CyPA may lead to drug resistance</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013410f4"/>
    </fig>
    <fig id="fig5">
      <label>Figure 5</label>
      <caption>
        <p>CyPA promotes neurodegeneration. ApoE2 and ApoE3 secreted by astrocytes, but not ApoE4, stimulates the low-density lipoprotein receptor-related protein 1 (LRP1) on pericytes. This event suppresses the pro-inflammatory pathway orchestrated by CyPA that leads to NF-kB and MMP-9 activation. As a consequence, the MMP-9-mediated degradation of tight junction and basement membrane proteins that causes BBB breakdown and neuronal dysfunction is inhibited</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cddis2013410f5"/>
    </fig>
    <table-wrap id="tbl1">
      <label>Table 1</label>
      <caption>
        <title>Major CyPA functions in protein folding and trafficking, T-cell activation and cell signaling</title>
      </caption>
      <table frame="hsides" rules="groups" border="1">
        <colgroup>
          <col align="left"/>
          <col align="left"/>
          <col align="left"/>
          <col align="center"/>
        </colgroup>
        <thead valign="bottom">
          <tr>
            <th align="left" valign="top" charoff="50">
              <bold>CyPA functions</bold>
            </th>
            <th align="left" valign="top" charoff="50">
              <bold>CyPA targets</bold>
            </th>
            <th align="left" valign="top" charoff="50">
              <bold>CyPA effects</bold>
            </th>
            <th align="center" valign="top" charoff="50">
              <bold>References</bold>
            </th>
          </tr>
        </thead>
        <tbody valign="top">
          <tr>
            <td align="left" valign="top" charoff="50">Folding</td>
            <td align="left" valign="top" charoff="50">HIV-1 Gag</td>
            <td align="left" valign="top" charoff="50">Promotion of both the formation and the infectivity of virions of HIV-1</td>
            <td align="center" valign="top" charoff="50">
              <sup><xref ref-type="bibr" rid="bib5">5</xref>, <xref ref-type="bibr" rid="bib6">6</xref></sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">Homo-oligomeric a7 neuronal nicotinic receptor (nAChR) and type 3 serotonin receptor (5HT3R)</td>
            <td align="left" valign="top" charoff="50">Maturation of the homo-oligomeric receptor</td>
            <td align="center" valign="top" charoff="50">
              <sup><xref ref-type="bibr" rid="bib7">7</xref>, <xref ref-type="bibr" rid="bib8">8</xref></sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">Collagen</td>
            <td align="left" valign="top" charoff="50">Acceleration of the folding of the procollagen I</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib9">9</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">Transferrin</td>
            <td align="left" valign="top" charoff="50">Acceleration of an initial stage in transferrin folding</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib10">10</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">
              <italic>Drosophila rhodopsin</italic>
            </td>
            <td align="left" valign="top" charoff="50">Folding and stability of R1-6 rhodopsin by the NinaA-encoded protein (an eye-specific CyP)</td>
            <td align="center" valign="top" charoff="50">
              <sup><xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref></sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">Trafficking</td>
            <td align="left" valign="top" charoff="50">Apoptosis-inducing factor (AIF)</td>
            <td align="left" valign="top" charoff="50">Co-translocation to the neuronal nuclei to induce cell death after cerebral hypoxia-ischemia and ALS</td>
            <td align="center" valign="top" charoff="50">
              <sup><xref ref-type="bibr" rid="bib13">13</xref>, <xref ref-type="bibr" rid="bib14">14</xref></sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">Heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2)</td>
            <td align="left" valign="top" charoff="50">CXCR4-mediated nuclear export of hnRNP A2, nuclear translocation of ERK1/2, and chemotactic cell migration</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib15">15</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">CD147</td>
            <td align="left" valign="top" charoff="50">Transport to the plasma membrane</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib16">16</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">Asialoglycoprotein receptor (ASGPR)</td>
            <td align="left" valign="top" charoff="50">Distribution of ASGPR between the plasma membrane and the endosomal pool</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib17">17</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">Fructose-1,6-bisphosphatase (FBPase)</td>
            <td align="left" valign="top" charoff="50">Import of FBPase into intermediate transport vesicles for vacuole delivery</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib18">18</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">Zinc-finger protein 1 (Zpr1)</td>
            <td align="left" valign="top" charoff="50">Promotion of nuclear export</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib19">19</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">T-cell activation</td>
            <td align="left" valign="top" charoff="50">Interleukin-2 tyrosine kinase (Itk)</td>
            <td align="left" valign="top" charoff="50">Positive regulation of Th1 profile and inhibition of Th2 differentiation</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib20">20</xref>
              </sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">Cell Signaling</td>
            <td align="left" valign="top" charoff="50">ERK1/2</td>
            <td align="left" valign="top" charoff="50">Stimulation of VSMC growth</td>
            <td align="center" valign="top" charoff="50">
              <sup><xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref></sup>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" charoff="50">&#xA0;</td>
            <td align="left" valign="top" charoff="50">JNK, p38 kinase, and IkB, NF-kB, E-selectin, and VCAM-1</td>
            <td align="left" valign="top" charoff="50">Stimulation EC apoptosis and inflammation</td>
            <td align="center" valign="top" charoff="50">
              <sup>
                <xref ref-type="bibr" rid="bib23">23</xref>
              </sup>
            </td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>